Makoto Wakahara
Yonago, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Long-Term Response to Pembrolizumab in Metastatic Metaplastic Breast Carcinoma: A Case Report.
Journal: The American journal of case reports
Published: May 16, 2026
Trastuzumab deruxtecan rechallenge in HER2-positive metastatic breast cancer: EN-SEMBLE.
Journal: Breast (Edinburgh, Scotland)
Published: April 20, 2026
Safety and effectiveness of post-trastuzumab deruxtecan regimens in patients with HER2-positive metastatic breast cancer who discontinued trastuzumab deruxtecan due to interstitial lung disease.
Journal: Breast (Edinburgh, Scotland)
Published: December 18, 2025
Reliability of Ki67-Labeling Index in Core Needle Biopsy Specimens of ER+/HER2- Breast Cancers.
Journal: Pathology international
Published: December 03, 2024
Case Report of Occult Breast Cancer with Triple Negative Subtype
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: April 21, 2024
Perineural Invasion Predicts Unfavorable Prognosis in Patients With Invasive Breast Cancer.
Journal: Cancer diagnosis & prognosis
Published: November 09, 2022
Clinical Significance of Subcellular Localization of Maspin in Breast Carcinoma: An Immunohistochemical Study Using Two Different Antibodies.
Journal: Yonago acta medica
Published: October 31, 2022
Clinical Significance of Serglycin Expression in Human Breast Cancer Patients.
Journal: Anticancer research
Published: October 21, 2021
Podoplanin expression in cancer-associated fibroblasts predicts unfavorable prognosis in node-negative breast cancer patients with hormone receptor-positive/HER2 - negative subtype.
Journal: Breast cancer (Tokyo, Japan)
Published: September 24, 2020
Upregulation of glucose and amino acid transporters in micropapillary carcinoma.
Journal: Histology and histopathology
Published: March 12, 2019
Last Updated: 09/26/2026